NVDA After the Beat: Why the Options Market Didn’t Celebrate
Record revenue. Record guidance. And the stock still drifted lower. Here's what that tells options traders right now.
MercadoLibre Is Growing at 49% and the Market Is Barely Paying Attention
Latin America's e-commerce and fintech giant just posted its fastest revenue growth in four years. So why is it still…
New Fed Chair, Rising Rate Hike Odds, and a Market That’s Still Near All-Time Highs — Something Has to Give
Kevin Warsh just replaced Jerome Powell. Inflation is at 3.8%. The FedWatch Tool is pricing in rate hikes, not cuts.…
The ‘Security Supercycle’ Is Real. Here’s the Cheapest Way to Sit Inside It.
Defense budgets are hitting records. Backlogs are at all-time highs. And U.S. defense names still trade at a discount to…
Carvana Just Posted Its Best Quarter Ever. The Stock Is Down 16% on the Year Anyway.
Record revenue, record EBITDA, record units. The market still isn't sure what to do with CVNA.
Nvidia’s Biggest Quarter Ever — and the Market Shrugged. Now What?
NVDA just delivered $81.6B in revenue and record net income. The post-earnings drift tells a more complicated story.
Micron’s Memory Is No Longer a Commodity. The Market Is Starting to Figure That Out.
MU just reported $23.86B in quarterly revenue — up nearly 3x year-over-year. Here's why the real story is still being…
Eli Lilly (LLY): The GLP-1 Trade Is Bigger Than the Market Thinks
Mounjaro up 125%. Zepbound up 79%. A new oral pill just launched. The growth story keeps widening.
Micron Just Crossed $1 Trillion. Here’s What Changed.
A single analyst call rewired how Wall Street thinks about memory chips — and MU hasn't looked back.
LLY and the GLP-1 Franchise: What the Options Market Knows That the Headlines Don’t
Eli Lilly's Q1 blowout reset the ceiling — and the options flow is telling a very specific story